Results 231 to 240 of about 358,222 (414)

Manufacturing and Biological Potential of Saliva‐Loaded Core‐Sheath Pressure‐Spun Polymeric Fibers

open access: yesMacromolecular Materials and Engineering, EarlyView.
The research highlights the creation and evaluation of saliva‐loaded core (polycaprolactone)‐sheath (polyethylene oxide) fibers. By employing a pressurized gyration technique to incorporate artificial saliva into the fibers, the study reveals promising results in antibacterial performance and wound treatment potential.
Vansh Thukral   +6 more
wiley   +1 more source

Investigation of hepatitis E virus seroprevalence and risk factors in hemodialysis patients. [PDF]

open access: yesFront Public Health
Öztürk H   +7 more
europepmc   +1 more source

Innovative Thermosensitive Composite Materials: Merging Poloxamer PF‐127 and Polysaccharides for Enhanced Functional Properties

open access: yesMacromolecular Materials and Engineering, EarlyView.
The poloxamer Pluronic‐F‐127‐based hydrogels are improved by the implementation of polysaccharides with different concentration ranges and structural organizations. The interactions between the polysaccharide structures and the poloxamer micellar aggregation confer the system better rheological properties and longer drug release times explained by ...
Marcos Blanco‐López   +4 more
wiley   +1 more source

Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells

open access: yesScience immunology, 2017
P. Dai   +9 more
semanticscholar   +1 more source

The observations and experience of the Surgical Disaster Response Team from Ankara Etlik City Hospital in the earthquakes of February 6, 2023 in Türkiye. [PDF]

open access: yesUlus Travma Acil Cerrahi Derg
Özdemir Ü   +7 more
europepmc   +1 more source

β3‐Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims β3‐Adrenoceptor agonists such as mirabegron or vibegron reach pharmacokinetic steady‐state within a few days. However, maximum improvements in symptoms of the overactive bladder syndrome are reached at time points later than 4 weeks, that is, detrusor smooth muscle relaxation cannot fully explain clinical effects.
Martin C. Michel   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy